Showing results (141-150 of 335) with videos related to
Sort By:
Pageof 34
Cancer Letters|February 19, 2010
Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancerManabu Onimaru, Kenoki Ohuchida, Eishi Nagai, et al.Lung Cancer (Amsterdam, Netherlands)|February 12, 2015
Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft modelHeyan Li, Shuo Wang, Koichi Takayama, et al.Japanese Journal of Clinical Oncology|April 20, 2013
Phase II trial of erlotinib for Japanese patients with previously treated non-small-cell lung cancer harboring EGFR mutations: results of Lung Oncology Group in Kyushu (LOGiK0803)Kazuhiko Yamada, Koichi Takayama, Satoru Kawakami, et al.Cancer Immunology, Immunotherapy : CII|February 21, 2008
TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor modelHiroyuki Inoue, Mutsunori Iga, Meng Xin, et al.Respiratory Medicine Case Reports|October 13, 2018
Successful sequential treatment of refractory tumors caused by small cell carcinoma transformation and EGFR-T790M mutation diagnosed by repeated genetic testing in a patient with lung adenocarcinoma harboring epidermal growth factor receptor mutations: A case reportNaoya Nishioka, Tadaaki Yamada, Sachi Harita, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 22, 2023
SARS-CoV-2 RT-PCR as a universal screening on planned admission in asymptomatic patientsChie Yamamoto, Yoko Nukui, Keitaro Furukawa, et al.Cancers|September 14, 2024
The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective StudyHaruka Kuno, Naoya Nishioka, Tadaaki Yamada, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenovirusesZeng B Zhu, Sharmila K Makhija, Baogen Lu, et al.Pathology International|November 15, 2019
A rare case of pulmonary typical carcinoid with prominent acinic cell differentiation, resembling acinic cell carcinomaHiroshi Watanabe, Aya Miyagawa-Hayashino, Tatsuya Imabayashi, et al.Journal of Clinical Medicine|December 18, 2019
Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408Koichi Takayama, Junji Uchino, Masaki Fujita, et al.Pageof 34